Cassella James V
Insider CIK 1353528 · ALXA SVP, Research & Development, Director · CNCE Chief Development Officer · TRVI Chief Development Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-02-19 | 2026-02-20 | 215,000 | — | $0 | 215,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 257,500 | — | $0 | 257,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-09-30 | 2024-10-01 | 400,000 | — | $0 | 400,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 60,400 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 34,700 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 75,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 49,500 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 70,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 50,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 140,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer deriv | 2023-03-06 | 2023-03-06 | 42,430 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | U Tender | 2023-03-06 | 2023-03-06 | 80,595 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | D To issuer | 2023-03-06 | 2023-03-06 | 57,766 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-02-15 | 2023-02-16 | 3,762 | $8.34 | $31.4K | 173,061 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-01-30 | 2023-01-31 | 10,106 | $8.35 | $84.4K | 176,823 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2023-01-06 | 2023-01-09 | 2,893 | $7.25 | $21.0K | 186,929 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-02-14 | 2022-02-16 | 3,762 | $3.09 | $11.6K | 189,822 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 75,800 | — | $0 | 158,884 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2022-01-28 | 2022-02-01 | 34,700 | — | $0 | 193,584 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2022-01-05 | 2022-01-07 | 2,894 | $3.19 | $9.2K | 83,084 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2021-08-16 | 2021-08-17 | 8,086 | $3.28 | $26.5K | 85,978 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2021-02-16 | 2021-02-17 | 3,763 | $7.32 | $27.5K | 94,064 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2021-01-05 | 2021-01-07 | 60,400 | — | $0 | 60,400 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2021-01-05 | 2021-01-07 | 21,700 | — | $0 | 97,827 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2020-08-17 | 2020-08-19 | 4,354 | $10.37 | $45.2K | 76,127 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2020-02-14 | 2020-02-19 | 42,430 | — | $0 | 42,430 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2020-02-14 | 2020-02-19 | 28,216 | — | $0 | 80,481 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-02-13 | 2020-02-18 | 23,684 | — | $0 | 23,684 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2019-08-15 | 2019-08-19 | 31,100 | — | $0 | 52,265 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2019-03-31 | 2019-04-02 | 8,835 | $12.07 | $106.6K | 21,165 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2019-01-04 | 2019-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2018-04-17 | 2018-04-19 | 10,582 | $20.18 | $213.5K | 30,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-03 | 4,418 | $22.90 | $101.2K | 55,582 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | F Tax w/h | 2018-03-31 | 2018-04-13 | 4,418 | $22.90 | $101.2K | 40,582 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2018-01-04 | 2018-01-08 | 49,500 | — | $0 | 49,500 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award | 2017-07-06 | 2017-07-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-01-04 | 2017-01-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-01-07 | 2016-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2015-03-05 | 2015-03-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2014-07-07 | 2014-07-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2014-06-27 | 2014-06-30 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2013-03-29 | 2013-04-02 | 43,750 | — | $0 | 43,750 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2013-03-29 | 2013-04-02 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2013-03-29 | 2013-04-02 | 43,750 | $4.42 | $193.4K | 62,495 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2013-03-29 | 2013-04-02 | 43,750 | $4.42 | $193.4K | 62,495 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2013-02-07 | 2013-02-08 | 17,795 | — | $0 | 18,745 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | S Sale | 2012-12-26 | 2012-12-27 | 4,558 | $4.90 | $22.3K | 950 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | S Sale | 2012-08-27 | 2012-08-29 | 10,000 | $4.14 | $41.4K | 5,508 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2012-07-26 | 2012-07-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award deriv | 2012-07-26 | 2012-07-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | S Sale | 2012-06-06 | 2012-06-08 | 46,222 | $0.34 | $15.7K | 157,801 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2012-05-10 | 2012-05-14 | 100,000 | — | $0 | 204,023 | SEC↗ |
| ALXA Alexza Pharmaceuticals Inc | A Award | 2012-03-23 | 2012-03-26 | 46,222 | — | $0 | 104,023 | SEC↗ |